Decision-Making About Potentially Non-Beneficial Intensive Care Unit Treatments: Interviews of Family Members from an Academic Public Hospital
Related Posts
Bucha S, Martin MJ, Feldman WB. The Pharmaceutical Industry's Quiet Win in the One Big Beautiful Bill Act. Ann Intern Med. 2025 Dec 30. doi:[...]
Vignolle GA, Tegel L, Schönthaler S, Walochnik J, Barišić I. Genome sequence of the protist Acanthamoeba comandoni strain Pb30/40, morphological group I. Microbiol Resour Announc. 2025 Dec[...]
Thaker SK, Silverstein J, Konecny GE, Bardia A. Trastuzumab deruxtecan and the evolving role of human epidermal growth factor receptor 2-targeted antibody-drug conjugates in breast[...]